Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation
โ Scribed by Z Ben-Ari; E Mor; N Bar-Nathan; E Shaharabani; Z Shapira; R Tur-Kaspa
- Book ID
- 117233147
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 57 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The outcome of hepatitis C virus (HCV) infection on patient and graft survival after orthotopic liver transplantation (OLT) has been controversial. An earlier experience with a higher dose of tacrolimus (H0.1 mg/kg/d intravenously and H0.2 mg/ kg/d orally) was associated with a worse clinical outcom
The introduction of calcineurin inhibitors has improved graft survival in the last 25 years. [1][2][3] The superiority of tacrolimus over cyclosporine (CsA) was well established in preventing acute rejection and corticosteroid-resistant rejection from 3 large randomized trials after liver transplant